Swiss Re has continued its long-running Vita Capital series of transactions with the issue of $50mn of notes in the first transfer of extreme mortality exposure since November last year.
Swiss Re has continued its long-running Vita Capital series of transactions with the issue of $50mn of notes in the first transfer of extreme mortality exposure since November last year.